---
figid: PMC3775402__IJCB2013-568931.002
figtitle: Alternative splicing regulation of the PI3K-mTOR pathway
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC3775402
filename: IJCB2013-568931.002.jpg
figlink: /pmc/articles/PMC3775402/figure/fig2/
number: F2
caption: 'Alternative splicing regulation of the PI3K-mTOR pathway. Growth factors
  and cytokines activate receptor tyrosine kinases (RTKs) which in turn lead to activation
  of PI3K. PI3K phosphorylates phospholipids inducing the recruitment of Akt to the
  plasma membrane and its activation by PDK1. A splicing variant of the catalytic
  subunit of PI3K (p37 delta) is an active form that enhances PI3K activity. Akt phosphorylates
  and inactivates the tumor suppressor TSC2, which inhibits the small GTPase Rheb.
  GTP-bound Rheb can activate mTOR. mTORβ is an active splicing isoform of mTOR. mTOR
  phosphorylates S6K1 and 4E-PB1. 4E-BP1 phosphorylation induces its release from
  eIF4E, enhancing cap-dependent translation and malignant transformation. Oncogenic
  splicing factor SRSF1 can affect the alternative splicing of S6K1 inducing oncogenic
  short isoforms of this kinase (h6A, h6C) which bind mTOR and enhance 4E-BP1 phosphorylation
  and cap-dependent translation. Blue: tumor suppressors, red: oncogenes.'
papertitle: Regulation of the Ras-MAPK and PI3K-mTOR Signalling Pathways by Alternative
  Splicing in Cancer.
reftext: Zahava Siegfried, et al. Int J Cell Biol. 2013;2013:568931.
year: '2013'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9581468
figid_alias: PMC3775402__F2
figtype: Figure
redirect_from: /figures/PMC3775402__F2
ndex: c14c14d9-debf-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3775402__IJCB2013-568931.002.html
  '@type': Dataset
  description: 'Alternative splicing regulation of the PI3K-mTOR pathway. Growth factors
    and cytokines activate receptor tyrosine kinases (RTKs) which in turn lead to
    activation of PI3K. PI3K phosphorylates phospholipids inducing the recruitment
    of Akt to the plasma membrane and its activation by PDK1. A splicing variant of
    the catalytic subunit of PI3K (p37 delta) is an active form that enhances PI3K
    activity. Akt phosphorylates and inactivates the tumor suppressor TSC2, which
    inhibits the small GTPase Rheb. GTP-bound Rheb can activate mTOR. mTORβ is an
    active splicing isoform of mTOR. mTOR phosphorylates S6K1 and 4E-PB1. 4E-BP1 phosphorylation
    induces its release from eIF4E, enhancing cap-dependent translation and malignant
    transformation. Oncogenic splicing factor SRSF1 can affect the alternative splicing
    of S6K1 inducing oncogenic short isoforms of this kinase (h6A, h6C) which bind
    mTOR and enhance 4E-BP1 phosphorylation and cap-dependent translation. Blue: tumor
    suppressors, red: oncogenes.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PTEN
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - STK11
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - TSC2
  - RHEB
  - RHEBP1
  - SRSF1
  - MTOR
  - EIF1
  - SRR
  - RPS6KB1
  - EIF4EBP1
  - EIF4E
  - EIF4E2
  - EIF4E3
---
